- Home
- DHIL vs ETON Comparison
DHIL vs ETON Comparison
Compare DHIL & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHIL
- ETON
- Stock Information
- Founded
- DHIL 1990
- ETON 2017
- Country
- DHIL United States
- ETON United States
- Employees
- DHIL N/A
- ETON N/A
- Industry
- DHIL Investment Managers
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- DHIL Finance
- ETON Health Care
- Exchange
- DHIL Nasdaq
- ETON Nasdaq
- Market Cap
- DHIL 370.3M
- ETON 428.5M
- IPO Year
- DHIL 1995
- ETON 2018
- Fundamental
- Price
- DHIL $138.69
- ETON $18.71
- Analyst Decision
- DHIL
- ETON Strong Buy
- Analyst Count
- DHIL 0
- ETON 3
- Target Price
- DHIL N/A
- ETON $29.67
- AVG Volume (30 Days)
- DHIL 13.9K
- ETON 366.2K
- Earning Date
- DHIL 04-29-2025
- ETON 05-13-2025
- Dividend Yield
- DHIL 4.25%
- ETON N/A
- EPS Growth
- DHIL 0.69
- ETON N/A
- EPS
- DHIL 14.79
- ETON N/A
- Revenue
- DHIL $151,916,411.00
- ETON $48,327,000.00
- Revenue This Year
- DHIL N/A
- ETON $98.26
- Revenue Next Year
- DHIL N/A
- ETON $51.64
- P/E Ratio
- DHIL $9.55
- ETON N/A
- Revenue Growth
- DHIL 9.28
- ETON 40.88
- 52 Week Low
- DHIL $122.32
- ETON $3.18
- 52 Week High
- DHIL $173.25
- ETON $21.48
- Technical
- Relative Strength Index (RSI)
- DHIL 48.40
- ETON 58.96
- Support Level
- DHIL $140.71
- ETON $18.69
- Resistance Level
- DHIL $144.68
- ETON $21.10
- Average True Range (ATR)
- DHIL 2.32
- ETON 1.46
- MACD
- DHIL -0.25
- ETON -0.15
- Stochastic Oscillator
- DHIL 35.42
- ETON 51.31
About DHIL Diamond Hill Investment Group Inc.
Diamond Hill Investment Group Inc sponsors, markets, and provides investment advisory and related services to various U.S. and foreign clients including mutual funds, separate accounts, and private investment funds. The company's objective is to fulfill a fiduciary duty to clients and secondary objectives to achieve an adequate long-term return for shareholders. The company generates its revenue from Investment advisory and fund administration fees.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.